Beyond Air, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Beyond Air, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $5.69M, a 786.92% increase year-over-year.
- Beyond Air, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $2.44M.
- Beyond Air, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $642.00K, a 6.69% decline year-over-year.
- Beyond Air, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $5.47M.
- Beyond Air, Inc. stock issued during period, value, new issues for fiscal 2026 was $8.13M, a 278.20% increase from fiscal 2025.
- Beyond Air, Inc. stock issued during period, value, new issues for fiscal 2025 was $2.15M, a 83.92% decline from fiscal 2024.
- Beyond Air, Inc. stock issued during period, value, new issues for fiscal 2024 was $13.38M, a 261.05% increase from fiscal 2023.
- Beyond Air, Inc. stock issued during period, value, new issues for fiscal 2023 was $3.71M, a 89.85% decline from fiscal 2022.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $8.13M 10-K · filed 2026-06-26 | |
| 2025-09-30 | $5.69M 10-Q · filed 2026-02-13 | |
| 2025-06-30 | $2.44M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $2.15M 10-K · filed 2026-06-26 | |
| 2024-09-30 | $642.00K 10-Q · filed 2026-02-13 | |
| 2024-03-31 | $13.38M 10-K · filed 2025-06-20 | |
| 2023-12-31 | $5.47M 10-Q · filed 2025-02-10 | |
| 2023-09-30 | $688.00K 10-Q · filed 2025-02-10 | |
| 2023-06-30 | $5.81M 10-Q · filed 2025-02-10 | |
| 2023-03-31 | $3.71M 10-K · filed 2024-06-24 | |
| 2022-09-30 | $214.00K 10-Q · filed 2024-02-12 | |
| 2022-03-31 | $36.49M 10-K · filed 2023-06-22 | |
| 2021-12-31 | $14.05M 10-Q · filed 2023-02-10 | |
| 2021-09-30 | $14.96M 10-Q · filed 2023-02-10 | |
| 2021-06-30 | $7.48M 10-Q · filed 2023-02-10 | |
| 2021-03-31 | $11.86M 10-K · filed 2022-06-29 | |
| 2020-12-31 | $3.13M 10-Q · filed 2022-02-10 | |
| 2020-09-30 | $1.54M 10-Q · filed 2022-02-10 | |
| 2020-06-30 | $900.00K 10-Q · filed 2022-02-10 | |
| 2019-09-30 | $808.18K 10-Q · filed 2020-02-07 | $2.80M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $1.17M 10-Q · filed 2021-02-09 | $1.97M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $772.01K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-23 | $799.18K 10-K · filed 2020-06-23 |
| 2018-12-31 | $45.67K 10-Q · filed 2020-02-07 | |
| 2018-09-30 | -$18.50K 10-Q · filed 2020-02-07 | |
| 2018-03-31 | $8.73M 10-Q · filed 2018-08-14 | $8.73M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-12-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15 | $6.32M 10-KT · filed 2018-06-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2017-03-31 | $6.32M 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |